The Center for Drug Design (CDD) was formed to combine research and scholarship leading to the development of novel drugs to treat HIV and other infectious diseases, neurological disorders, cancer, and dermatological conditions.
The Center for Drug Design is dedicated to:
- Providing a research environment for leading scientists
- Sharing unique strategies within the scientific community
- Developing novel drug therapies
- Vigorously pursuing an academic research agenda
- Supporting the interaction of many disciplines and areas of study
- Creating a focal point for research
The Center for Drug Design is supported in part by royalty income through a drug company licensing agreement. Funds support faculty, administrative and research staff, postdoctoral fellows, and facility costs.